These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27834791)

  • 21. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24.
    Monaco-Malbet S; Berthet-Colominas C; Novelli A; Battaï N; Piga N; Cheynet V; Mallet F; Cusack S
    Structure; 2000 Oct; 8(10):1069-77. PubMed ID: 11080628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refining the Quality of Monoclonal Antibodies: Grafting Unique Peptide-Binding Site in the Fab Framework.
    King JD; Williams JC
    Methods Mol Biol; 2019; 1904():293-298. PubMed ID: 30539475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1.
    Braden BC; Souchon H; Eiselé JL; Bentley GA; Bhat TN; Navaza J; Poljak RJ
    J Mol Biol; 1994 Nov; 243(4):767-81. PubMed ID: 7966295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen.
    Wojciak JM; Zhu N; Schuerenberg KT; Moreno K; Shestowsky WS; Hiraiwa M; Sabbadini R; Huxford T
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17717-22. PubMed ID: 19815502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative analysis of the immunological evolution of antibody 28B4.
    Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG
    Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition.
    Fellouse FA; Wiesmann C; Sidhu SS
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12467-72. PubMed ID: 15306681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
    Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
    Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.
    Hülsmeyer M; Chames P; Hillig RC; Stanfield RL; Held G; Coulie PG; Alings C; Wille G; Saenger W; Uchanska-Ziegler B; Hoogenboom HR; Ziegler A
    J Biol Chem; 2005 Jan; 280(4):2972-80. PubMed ID: 15537658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic analysis of the effect on Fab binding of identical substitutions in a peptide and its parent protein.
    Choulier L; Rauffer-Bruyère N; Ben Khalifa M; Martin F; Vernet T; Altschuh D
    Biochemistry; 1999 Mar; 38(12):3530-7. PubMed ID: 10090739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8.
    Malia TJ; Teplyakov A; Ernst R; Wu SJ; Lacy ER; Liu X; Vandermeeren M; Mercken M; Luo J; Sweet RW; Gilliland GL
    Proteins; 2016 Apr; 84(4):427-34. PubMed ID: 26800003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons from the Crystal Structure of the S. aureus Surface Protein Clumping Factor A in Complex With Tefibazumab, an Inhibiting Monoclonal Antibody.
    Ganesh VK; Liang X; Geoghegan JA; Cohen ALV; Venugopalan N; Foster TJ; Hook M
    EBioMedicine; 2016 Nov; 13():328-338. PubMed ID: 27789272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered antigen-binding fragments for enhanced crystallization of antibody:antigen complexes.
    Bruce HA; Singer AU; Filippova EV; Blazer LL; Adams JJ; Enderle L; Ben-David M; Radley EH; Mao DYL; Pau V; Orlicky S; Sicheri F; Kurinov I; Atwell S; Kossiakoff AA; Sidhu SS
    Protein Sci; 2024 Jan; 33(1):e4824. PubMed ID: 37945533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different binding modes of free and carrier-protein-coupled nicotine in a human monoclonal antibody.
    Tars K; Kotelovica S; Lipowsky G; Bauer M; Beerli RR; Bachmann MF; Maurer P
    J Mol Biol; 2012 Jan; 415(1):118-27. PubMed ID: 22079050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A.
    Stanfield RL; Fieser TM; Lerner RA; Wilson IA
    Science; 1990 May; 248(4956):712-9. PubMed ID: 2333521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The crystal structures of complexes formed between lysozyme and antibody fragments.
    Bentley GA
    EXS; 1996; 75():301-19. PubMed ID: 8765306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between a Fab fragment against gp41 of human immunodeficiency virus 1 and its peptide epitope: characterization using a peptide epitope library and molecular modeling.
    Stigler RD; Rüker F; Katinger D; Elliott G; Höhne W; Henklein P; Ho JX; Keeling K; Carter DC; Nugel E
    Protein Eng; 1995 May; 8(5):471-9. PubMed ID: 8532669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.